ZECP - ETF AI Analysis
Top Page
Zacks Earnings Consistent Portfolio ETF (ZECP)
ZECP’s rating suggests it is a solid, but not risk‑free, ETF built around companies with consistent earnings strength. Major holdings like Alphabet, Microsoft, and Apple boost the fund’s quality through strong financial performance, leadership in technology, and positive long-term growth drivers such as cloud and AI. However, some positions like Cardinal Health and highly leveraged names introduce risks related to debt and potential overvaluation, and the fund’s heavy tilt toward large tech and financial companies means it is exposed to sector-specific swings.
ZECP vs. SPDR S&P 500 ETF (SPY)
- AUM
- 388.87M
- Region
- North America
- Expense Ratio
- 0.55%
- Beta
- 0.74
- Issuer
- Zacks
- Inception Date
- Aug 24, 2021
- Dividend Yield
- 0.72%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ZECP Summary
ZECP is the Zacks Earnings Consistent Portfolio ETF, built around a simple theme: owning U.S. companies with steady, reliable earnings rather than chasing the latest trend. It doesn’t track a traditional index, but instead selects firms across many sectors, including technology, health care, financials, and consumer goods. Well-known holdings include Apple and Microsoft, along with companies like JPMorgan Chase and Walmart, giving investors broad diversification with a tilt toward proven businesses. Someone might invest in ZECP to seek more stable long-term growth. A key risk is that it can still go up and down with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because ZECP is actively managed, selecting companies with consistent earnings rather than simply tracking a broad market index.
What would affect this ETF?
ZECP focuses on U.S. companies with steady earnings, so it could benefit if the economy remains stable, large tech and financial firms like Apple, Microsoft, Alphabet, and JPMorgan keep growing profits, and investors favor dependable, diversified portfolios. On the downside, rising interest rates, a U.S. recession, or new regulations that hurt big technology, health care, or financial companies could pressure these key holdings and reduce the fund’s overall performance.
ZECP Top 10 Holdings
ZECP leans heavily into U.S. Big Tech, with Apple and Microsoft doing much of the heavy lifting. Apple has been rising steadily, while Microsoft’s longer-term gains help offset its recent wobble. Alphabet is more mixed, losing a bit of steam lately but still a key growth engine. Outside tech, Caterpillar and Applied Materials add an industrial and semiconductor twist, both coming off strong runs despite some recent choppiness. Financial names like JPMorgan and American Express are more of a mixed bag, occasionally dragging on what is otherwise a tech-led, U.S.-focused story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 8.37% | $32.76M | $5.02T | 27.82% | 79Outperform |
 MSFT | Microsoft | 7.86% | $30.77M | $3.94T | -2.04% | 79Outperform |
 GOOGL | Alphabet Class A | 6.88% | $26.94M | $3.96T | 21.47% | 85Outperform |
 JPM | JPMorgan Chase | 3.25% | $12.72M | $901.92B | 11.11% | 72Outperform |
 LLY | Eli Lilly & Co | 3.00% | $11.73M | $1.21T | 57.09% | 72Outperform |
 WMT | Walmart | 2.83% | $11.08M | $942.29B | 15.12% | 78Outperform |
 AXP | American Express | 2.29% | $8.94M | $213.20B | -11.94% | 80Outperform |
 CAH | Cardinal Health | 2.04% | $8.00M | $56.68B | 50.35% | 66Neutral |
 PG | Procter & Gamble | 2.04% | $7.96M | $366.81B | 4.55% | 69Neutral |
 AEP | American Electric Power | 1.85% | $7.23M | $69.79B | 11.37% | 69Neutral |
ZECP Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ZECP, the sentiment is Positive. The current price of 38.27 is above the 20-day moving average (MA) of 37.87, above the 50-day MA of 37.78, and above the 200-day MA of 36.65, indicating a bullish trend. The MACD of 0.16 indicates Negative momentum. The RSI at 56.75 is Neutral, neither overbought nor oversold. The STOCH value of 47.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ZECP.
ZECP Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ZECP | $38.27 | $42.00(9.75% Upside) | $388.87M | 0.55% | 74Outperform |
 SEUS | $26.00 | $30.81(18.48% Upside) | $943.10M | 0.30% | 73Outperform |
 BGDV | $31.20 | $36.87(18.19% Upside) | $865.45M | 0.45% | 74Outperform |
 AAUB | $51.12 | $60.44(18.25% Upside) | $841.51M | 0.10% | 66Neutral |
 AVTM | $54.87 | $64.41(17.39% Upside) | $774.92M | 0.22% | 60Neutral |
 SMRI | $46.79 | $56.68(21.12% Upside) | $706.91M | 0.71% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ZECP | Zacks Earnings Consistent Portfolio ETF | 38.27 | 4.30 | 12.64% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 26.00 | 0.74 | 2.91% | |
| BGDV | Bahl & Gaynor Dividend ETF | 31.20 | 4.79 | 18.14% | |
| AAUB | Alpha Architect US Equity 4 ETF | 51.12 | 1.63 | 3.30% | |
| AVTM | Avantis Total Equity Markets ETF | 54.87 | 5.23 | 10.53% | |
| SMRI | Bushido Capital US Equity ETF | 46.79 | 12.67 | 37.14% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.